Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903)

BACKGROUND: Neoadjuvant therapy plus oesophagectomy has been accepted as the standard treatment for patients with potentially curable locally advanced oesophageal cancer. No completed randomized controlled trial (RCT) has directly compared neoadjuvant chemotherapy and neoadjuvant chemoradiation in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Hai-Bo, Xing, Wen-Qun, Liu, Xian-Ben, Zheng, Yan, Yang, Shu-Jun, Wang, Zong-Fei, Liu, Shi-Lei, Ba, Yu-Feng, Zhang, Rui-Xiang, Liu, Bao-Xing, Fan, Cheng-Cheng, Chen, Pei-Nan, Liang, Guang-Hui, Yu, Yong-Kui, Liu, Qi, Wang, Hao-Ran, Li, Hao-Miao, Li, Zhen-Xuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158003/
https://www.ncbi.nlm.nih.gov/pubmed/32293362
http://dx.doi.org/10.1186/s12885-020-06824-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158003/
https://www.ncbi.nlm.nih.gov/pubmed/32293362
http://dx.doi.org/10.1186/s12885-020-06824-2

Ejemplares similares